Biogen posts marginal rise in first-quarter sales
April 22, 2020 at 07:13 AM EDT
Biogen Inc posted a 1.3% rise in first-quarter sales on Wednesday, helped by demand for its spinal muscular atrophy drug as well as its multiple sclerosis treatment, Tecfidera.